Recall of Care Objectives by Patients with Inflammatory Bowel Diseases.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 1, p. 49, doi. 10.3390/gidisord4010006
- By:
- Publication type:
- Article
Works matching IS 26245647 AND DT 2022 AND VI 4 AND IP 1
Results: 6
1
2
Probiotics and Phytochemicals: Role on Gut Microbiota and Efficacy on Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 1, p. 5, doi. 10.3390/gidisord4010005
- By:
- Publication type:
- Article
3
Measurement of Pain and Related Symptoms in Irritable Bowel Syndrome: The Use of Validated Pain Measurement Tools.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 1, p. 22, doi. 10.3390/gidisord4010004
- By:
- Publication type:
- Article
4
The Role of Vitamin K in Cirrhosis: Do Pharmaco-K-Netics Matter?
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 1, p. 15, doi. 10.3390/gidisord4010003
- By:
- Publication type:
- Article
5
Evidence of On-Going Disparate Levels of Care for South Asian Patients with Inflammatory Bowel Disease in the United Kingdom during the Quinquennium 2015–2019.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 1, p. 8, doi. 10.3390/gidisord4010002
- By:
- Publication type:
- Article
6
Disaccharidase Deficiency in Pediatric Patients with Inflammatory Bowel Disease.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 1, p. 1, doi. 10.3390/gidisord4010001
- By:
- Publication type:
- Article